Skip to content

Welcome to Discover Pharma! Today is : October 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Cancer Research

  • Advanced Therapies,Drug Discovery & Development,Therapeutic Areas

    Why immunotherapy sometimes fails: Study reveals unintended effects of antibody design

    A new study from researchers in Japan has uncovered a [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    START and OneOncology expand access to early phase cancer trials in US communities

    A new partnership will bring early phase clinical trials closer [...]

    May 5, 2026
  • Advanced Therapies

    Cycuria Therapeutics launches with advisory board and major grant funding

    May 5, 2026
  • Advanced Therapies

    BioSkryb Genomics and Tecan launch single-cell multiomics workflow for faster sequencing

    May 5, 2026
  • Drug Delivery & Formulation

    Carthera hits major recruitment milestone in glioblastoma trial using BBB-opening ultrasound device

    Carthera has enrolled the first 100 participants in its Sonobird [...]

    April 24, 2025
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nabsys launches RepX for repeat expansion analysis
    Categories: Genomics and sequencing
  • NICE recommends maralixibat for Alagille syndrome itching
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Mursla Bio validates liver-specific liquid biopsy platform
    Categories: Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top